429 related articles for article (PubMed ID: 17397875)
21. Preventive effect of melatonin on bleomycin-induced lung fibrosis in rats.
Yildirim Z; Kotuk M; Erdogan H; Iraz M; Yagmurca M; Kuku I; Fadillioglu E
J Pineal Res; 2006 Jan; 40(1):27-33. PubMed ID: 16313495
[TBL] [Abstract][Full Text] [Related]
22. Differential effects of pirfenidone on acute pulmonary injury and ensuing fibrosis in the hamster model of amiodarone-induced pulmonary toxicity.
Card JW; Racz WJ; Brien JF; Margolin SB; Massey TE
Toxicol Sci; 2003 Sep; 75(1):169-80. PubMed ID: 12832656
[TBL] [Abstract][Full Text] [Related]
23. Effects of montelukast on subepithelial/peribronchial fibrosis in a murine model of ovalbumin induced chronic asthma.
Shin IS; Jeon WY; Shin HK; Lee MY
Int Immunopharmacol; 2013 Nov; 17(3):867-73. PubMed ID: 24126112
[TBL] [Abstract][Full Text] [Related]
24. [The effect of curcumin on bleomycin-induced pulmonary fibrosis in rats].
Zhang DP; Qiu H; Zhuang Y; Meng FQ
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):197-201. PubMed ID: 17572999
[TBL] [Abstract][Full Text] [Related]
25. Suplatast tosilate prevents bleomycin-induced pulmonary fibrosis in mice.
Furonaka M; Hattori N; Tanimoto T; Senoo T; Ishikawa N; Fujitaka K; Haruta Y; Yokoyama A; Kohno N
J Pharmacol Exp Ther; 2009 Jan; 328(1):55-61. PubMed ID: 18832650
[TBL] [Abstract][Full Text] [Related]
26. Activation of somatostatin receptors attenuates pulmonary fibrosis.
Borie R; Fabre A; Prost F; Marchal-Somme J; Lebtahi R; Marchand-Adam S; Aubier M; Soler P; Crestani B
Thorax; 2008 Mar; 63(3):251-8. PubMed ID: 17951277
[TBL] [Abstract][Full Text] [Related]
27. Bleomycin-induced pulmonary fibrosis is attenuated by an antibody against KL-6.
Xu L; Yang D; Zhu S; Gu J; Ding F; Bian W; Rong Z; Shen C
Exp Lung Res; 2013 Aug; 39(6):241-8. PubMed ID: 23672275
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of MMP9 in macrophages attenuates pulmonary fibrosis induced by bleomycin.
Cabrera S; Gaxiola M; Arreola JL; Ramírez R; Jara P; D'Armiento J; Richards T; Selman M; Pardo A
Int J Biochem Cell Biol; 2007; 39(12):2324-38. PubMed ID: 17702637
[TBL] [Abstract][Full Text] [Related]
29. Inhibitory effects of isoliensinine on bleomycin-induced pulmonary fibrosis in mice.
Xiao JH; Zhang JH; Chen HL; Feng XL; Wang JL
Planta Med; 2005 Mar; 71(3):225-30. PubMed ID: 15770542
[TBL] [Abstract][Full Text] [Related]
30. IL-10 inhibits inflammation but does not affect fibrosis in the pulmonary response to bleomycin.
Kradin RL; Sakamoto H; Jain F; Zhao LH; Hymowitz G; Preffer F
Exp Mol Pathol; 2004 Jun; 76(3):205-11. PubMed ID: 15126102
[TBL] [Abstract][Full Text] [Related]
31. Cysteinyl leukotriene receptor antagonist MK-571 alters bronchoalveolar lavage fluid proteome in a mouse asthma model.
Wong WS; Zhu H; Liao W
Eur J Pharmacol; 2007 Dec; 575(1-3):134-41. PubMed ID: 17689528
[TBL] [Abstract][Full Text] [Related]
32. Influence of early neutrophil depletion on MMPs/TIMP-1 balance in bleomycin-induced lung fibrosis.
Manoury B; Nénan S; Guénon I; Lagente V; Boichot E
Int Immunopharmacol; 2007 Jul; 7(7):900-11. PubMed ID: 17499192
[TBL] [Abstract][Full Text] [Related]
33. [The effect of murine interferon-gamma transgene expression on bleomycin-induced pulmonary fibrosis in mice].
Tian GZ; Gao ZC; Xu Y; Gai J; Dong JQ; He QY
Zhonghua Jie He He Hu Xi Za Zhi; 2003 May; 26(5):290-3. PubMed ID: 12892616
[TBL] [Abstract][Full Text] [Related]
34. [Effects of antisense oligonucleotide to nuclear factor-kappaB on the development of bleomycin-induced pulmonary fibrosis and IL-4 expression therein: experiment with mice].
Zhang XY; Zhou Y; Liu WQ; Zhao L; Li SQ
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):195-9. PubMed ID: 17425852
[TBL] [Abstract][Full Text] [Related]
35. Pranlukast, a cysteinyl leukotriene type 1 receptor antagonist, attenuates the progression but not the onset of silica-induced pulmonary fibrosis in mice.
Shimbori C; Shiota N; Okunishi H
Int Arch Allergy Immunol; 2012; 158(3):241-51. PubMed ID: 22378144
[TBL] [Abstract][Full Text] [Related]
36. Effects of delayed treatment with transforming growth factor-beta soluble receptor in a three-dose bleomycin model of lung fibrosis in hamsters.
Wang Q; Hyde DM; Gotwals PJ; Giri SN
Exp Lung Res; 2002 Sep; 28(6):405-17. PubMed ID: 12217209
[TBL] [Abstract][Full Text] [Related]
37. [Kinetics and mechanism in bleomycin-induced murine pulmonary fibrosis model].
Hu P; Gao ZC
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2006 Aug; 18(8):474-8. PubMed ID: 16887059
[TBL] [Abstract][Full Text] [Related]
38. Comparative study to elucidate the mechanism underlying the difference in airway hyperresponsiveness between two mouse strains.
Fukunaga J; Abe M; Murai A; Akitake Y; Hosokawa M; Takahashi M
Int Immunopharmacol; 2007 Dec; 7(14):1852-61. PubMed ID: 18039522
[TBL] [Abstract][Full Text] [Related]
39. Berberine attenuates bleomycin induced pulmonary toxicity and fibrosis via suppressing NF-κB dependant TGF-β activation: a biphasic experimental study.
Chitra P; Saiprasad G; Manikandan R; Sudhandiran G
Toxicol Lett; 2013 May; 219(2):178-93. PubMed ID: 23523906
[TBL] [Abstract][Full Text] [Related]
40. Resistance of fibrogenic responses to glucocorticoid and 2-methoxyestradiol in bleomycin-induced lung fibrosis in mice.
Langenbach SY; Wheaton BJ; Fernandes DJ; Jones C; Sutherland TE; Wraith BC; Harris T; Schuliga MJ; McLean C; Stewart AG
Can J Physiol Pharmacol; 2007 Jul; 85(7):727-38. PubMed ID: 17823636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
